Hematology

The Pharmacy Times® Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of blood disorders, include blood and bone marrow cancers, anemia, hemophilia, blood-clotting disorders, and leukemia.

Latest News

fda approved label. fda approved red band sign. fda approved | Image Credit: Aquir - stock.adobe.com
FDA Approves Vadadustat for Oral Treatment of Anemia Due to Chronic Kidney Disease

March 28th 2024

Vadadustat (Vafseo; Akebia Therapeutics Inc) is indicated for individuals with chronic kidney disease who have been receiving dialysis for at least 3 months.

Acute myeloid leukemia and stethoscope -- Image credit: Ekahardiwito | stock.adobe.com
Improvements Made in Stem Cell Transplant for Older Patients With AML Since 2000

March 27th 2024

Antiviral oral drug -- Image credit: shidlovski | stock.adobe.com
Nirmatrelvir/Ritonavir in Patients With Hematologic Malignancies Improves COVID-19 Outcomes

March 27th 2024

Mosquito sucking blood -- Image credit: corlaffra | stock.adobe.com
FDA Approves Cobas Malaria to Help Reduce Risks Infections From Transfused Blood Products

March 26th 2024

Pharmacists checking inventory at hospital pharmacy | Image Credit: Jacob Lund - stock.adobe.com
FDA Grants Fast Track Designation to Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia

March 26th 2024

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

1.5 Credits / Hematology, Oncology

View More

Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care

1.0 Credit / Hematology, Oncology

View More

Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy

1.0 Credit / Hematology, Oncology

View More

Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives

1.0 Credit / Hematology, Oncology

View More

Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role

1.0 Credit / Hematology, Oncology

View More

Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Navigating Current and Emerging Treatment Options for Myelofibrosis After Frontline Failure

1.0 Credit / Oncology

View More

Managed Care Considerations on the Evolving Role of Bispecific Antibodies in Hematologic Malignancies

1.5 Credits / Hematology, Oncology

View More

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

1.0 Credits / Hematology, Oncology

View More

Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team

1.5 Credits / Hematology, Oncology

View More

Advancing Myelofibrosis Treatment and Management With JAK Inhibitors and Specialty Pharmacist-led Strategies

1.5 Credits / Hematology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists

1.5 Credit / Hematology, Oncology

View More

Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist

1.5 Credit(s) / Hematology, Oncology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmac...

1.5 Credit / Hematology, Oncology

View More

Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists

1.0 Credit / Hematology, Oncology

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals

1.0 Credit / Hematology, Oncology

View More

Assessing Emerging Therapies and Multidisciplinary Practices in Managing Myelofibrosis

1.5 Credits / Hematology, Oncology

View More

Chronic Myeloid Leukemia: Navigating Drug Resistance and Optimizing Care

1.0 Credit / Hematologic Cancer, Hematology, Oncology

View More

Optimizing Use of Small Molecule Inhibitors in Chronic Lymphocytic Leukemia: Strategies for Safe and Effective Use

1.0 Credits / Hematology, Oncology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Management of DOAC-Associated Bleeding With Reversal Agents: A Comprehensive Approach for Health-System Pharmacists

1.0 Credit / Hematology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.